These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 24308218

  • 21. Association between end-stage diabetic nephropathy and MTHFR (C677T and A1298C) gene polymorphisms.
    Ramanathan G, Harichandana B, Kannan S, Elumalai R, Sfd P.
    Nephrology (Carlton); 2019 Feb; 24(2):155-159. PubMed ID: 29227003
    [Abstract] [Full Text] [Related]

  • 22. Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study.
    Russo GT, Di Benedetto A, Magazzù D, Giandalia A, Giorda CB, Ientile R, Previti M, Di Cesare E, Cucinotta D.
    Acta Diabetol; 2011 Jun; 48(2):95-101. PubMed ID: 19937354
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Genetic combination of angiotensin-converting enzyme with methylene tetrahydrofolate reductase polymorphisms and the risk of type 2 diabetes mellitus in Bahrain.
    Al-Harbi EM, Farid EM, Gumaa KA, Darwish AH, Alenizi M, Singh J.
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):172-7. PubMed ID: 23447104
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.
    Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS.
    Am J Kidney Dis; 2003 Jun; 41(6):1189-94. PubMed ID: 12776270
    [Abstract] [Full Text] [Related]

  • 28. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
    Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D, Stefanovic M.
    Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
    [Abstract] [Full Text] [Related]

  • 29. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
    Wiltshire EJ, Mohsin F, Chan A, Donaghue KC.
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
    [Abstract] [Full Text] [Related]

  • 30. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
    Ren A, Wang J.
    Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
    [Abstract] [Full Text] [Related]

  • 31. Relationship between genetic polymorphisms of angiotensin-converting enzyme and methylenetetrahydrofolate reductase as risk factors for type 2 diabetes in Tunisian patients.
    Mehri S, Koubaa N, Nakbi A, Hammami S, Chaaba R, Mahjoub S, Zouari B, Abid M, Ben Arab S, Baudin B, Hammami M.
    Clin Biochem; 2010 Feb; 43(3):259-66. PubMed ID: 19857476
    [Abstract] [Full Text] [Related]

  • 32. The association of the 174G>C polymorphism of interleukin 6 gene with diabetic nephropathy in patients with type 2 diabetes mellitus.
    Papaoikonomou S, Tentolouris N, Tousoulis D, Papadodiannis D, Miliou A, Papageorgiou N, Hatzis G, Stefanadis C.
    J Diabetes Complications; 2013 Feb; 27(6):576-9. PubMed ID: 23871133
    [Abstract] [Full Text] [Related]

  • 33. [Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy].
    Wang L, Wang J, Xue Y, Chen Y, Zou H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):276-8. PubMed ID: 11484165
    [Abstract] [Full Text] [Related]

  • 34. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J, Xu Y, Zhu Y, Lu H, Deng H, Fan Y, Sun S, Zhang Y.
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [Abstract] [Full Text] [Related]

  • 35. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
    Timuragaoglu A, Dizlek S, Uysalgil N, Tosun O, Yamac K.
    Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
    [Abstract] [Full Text] [Related]

  • 36. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y, Ng MC, So WY, Ma R, Ko GT, Tong PC, Chan JC.
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [Abstract] [Full Text] [Related]

  • 37. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP, Gala JL, Buysschaert M.
    Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
    [Abstract] [Full Text] [Related]

  • 38. [Relationship between methylenetrahydrofolate reductase gene and ischemic stroke].
    Li CM, Zhang C, Lu XL, Feng HY, Su QX, Zeng Y, Zhang HL, Qiu SL.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):264-7. PubMed ID: 16700986
    [Abstract] [Full Text] [Related]

  • 39. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
    Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Oztürk O, Isbir T.
    Cell Biochem Funct; 2007 May; 25(1):115-7. PubMed ID: 16134079
    [Abstract] [Full Text] [Related]

  • 40. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.